comparemela.com

Latest Breaking News On - Stock incentive plan - Page 2 : comparemela.com

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Zhongwen-justin-tang
Xiaopeng-jeff-cai
Linkedin
Nasdaq
Ocular-therapeutix-inc
Compensation-committee-of-ocular
Vice-president
Data-operations
Compensation-committee
Stock-incentive-plan
Nasdaq-listing-rule
Nasdaq-global-market

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Company-or-inozyme
Nasdaq
Stock-incentive-plan
Nasdaq-listing-rule

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today.

Boston
Massachusetts
United-states
Jen-robinson
Ashlea-kosikowski
Verve-therapeutics-inc
Nasdaq
Stock-incentive-plan
Nasdaq-listing-rule
Verve-therapeutics
Markets

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Jason-fredette
Nasdaq
Mersana-therapeutics-inc
Nasdaq-listing-rule
Stock-incentive-plan

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 (GLOBE NEWSWIRE) Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced

Boston
Massachusetts
United-states
Ashlea-kosikowski
Jen-robinson
Nasdaq
Verve-therapeutics-inc
Stock-incentive-plan
Nasdaq-listing-rule
Verve-therapeutics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.